These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26980242)

  • 21. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Kumar A; Davuluri G; Silva RNE; Engelen MPKJ; Ten Have GAM; Prayson R; Deutz NEP; Dasarathy S
    Hepatology; 2017 Jun; 65(6):2045-2058. PubMed ID: 28195332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of Hepatic Encephalopathy Using
    El-Baz FK; Elgohary R; Salama A
    Biomed Res Int; 2021; 2021():8843218. PubMed ID: 33855084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.
    Jover R; Rodrigo R; Felipo V; Insausti R; Sáez-Valero J; García-Ayllón MS; Suárez I; Candela A; Compañ A; Esteban A; Cauli O; Ausó E; Rodríguez E; Gutiérrez A; Girona E; Erceg S; Berbel P; Pérez-Mateo M
    Hepatology; 2006 Jun; 43(6):1257-66. PubMed ID: 16729306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ammonia: key factor in the pathogenesis of hepatic encephalopathy.
    Butterworth RF; Giguère JF; Michaud J; Lavoie J; Layrargues GP
    Neurochem Pathol; 1987; 6(1-2):1-12. PubMed ID: 3306479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
    Miquel M; Bartolí R; Odena G; Serafín A; Cabré E; Galan A; Barba I; Córdoba J; Planas R
    Liver Int; 2010 Aug; 30(7):979-87. PubMed ID: 20492509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.
    Espíritu-Ramírez P; Ortega-Balderas NY; Sevilla-Tapia L; Montiel-Martínez AG; Pastor-Flores AR; Palomares LA; Torres-Vega MA
    Ann Hepatol; 2018 Oct; 17(6):1026-1034. PubMed ID: 30600292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes.
    Lu K; Zimmermann M; Görg B; Bidmon HJ; Biermann B; Klöcker N; Häussinger D; Reichert AS
    EBioMedicine; 2019 Oct; 48():539-553. PubMed ID: 31648987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperammonemic coma--barking up the wrong tree.
    Rimar D; Kruzel-Davila E; Dori G; Baron E; Bitterman H
    J Gen Intern Med; 2007 Apr; 22(4):549-52. PubMed ID: 17372808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats.
    Odena G; Miquel M; Serafín A; Galan A; Morillas R; Planas R; Bartolí R
    World J Gastroenterol; 2012 May; 18(17):2084-91. PubMed ID: 22563196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-absorbable rifamycin for treatment of hepatic encephalopathy.
    Testa R; Eftimiadi C; Sukkar GS; De Leo C; Rovida S; Schito GC; Celle G
    Drugs Exp Clin Res; 1985; 11(6):387-92. PubMed ID: 3836135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure.
    Bosoi CR; Yang X; Huynh J; Parent-Robitaille C; Jiang W; Tremblay M; Rose CF
    Free Radic Biol Med; 2012 Apr; 52(7):1228-35. PubMed ID: 22300646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifaximin may have a dramatic effect on hepatic encephalopathy.
    Lamb C; Reddy AV
    Clin Med (Lond); 2012 Oct; 12(5):489-90. PubMed ID: 23101155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hepatic encephalopathy: focus on antibiotic therapy.
    Festi D; Vestito A; Mazzella G; Roda E; Colecchia A
    Digestion; 2006; 73 Suppl 1():94-101. PubMed ID: 16498257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifaximin for the treatment of hepatic encephalopathy.
    Mullen K; Prakash R
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):665-77. PubMed ID: 21108586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.
    Miglio F; Valpiani D; Rossellini SR; Ferrieri A
    Curr Med Res Opin; 1997; 13(10):593-601. PubMed ID: 9327194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo Evaluation of Succinic Acid-Substituted Mesoporous Silica for Ammonia Adsorption: Potential Application in the Management of Hepatic Encephalopathy.
    Mohammadi H; Heidari R; Niknezhad SV; Jamshidzadeh A; Farjadian F
    Int J Nanomedicine; 2020; 15():10085-10098. PubMed ID: 33363368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifaximin: new therapeutic indication and future directions.
    Rivkin A; Gim S
    Clin Ther; 2011 Jul; 33(7):812-27. PubMed ID: 21741091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genistein Alleviates Neuroinflammation and Restores Cognitive Function in Rat Model of Hepatic Encephalopathy: Underlying Mechanisms.
    Ganai AA; Husain M
    Mol Neurobiol; 2018 Feb; 55(2):1762-1772. PubMed ID: 28224477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.